ARTLNasdaqPharmaceutical PreparationsFiscal year ends December 31
ARTELO BIOSCIENCES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Aug 20, 2026
$2.66−0.04 (-1.48%)
Close on Oct 19, 2026
- Market cap
- $7.21M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$110.47 (−97.65%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $7.21M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 1.44
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$12.67M
- EPS, diluted
- -$12.52
- Book value per share
- $1.84
- Diluted shares
- 3M
Eleven years at a glance
Fiscal years 2014 to 2025 and trailing twelve months, USD
Operating income
-$11.07M
Net income
-$12.67M
EPS, diluted
–
Reported periodTrailing twelve months